Lazard Asset Management’s Adicet Bio ACET Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-414
| Closed | – | – | 2278 |
|
|
2024
Q4 | $0 | Hold |
414
| – | – | ﹤0.01% | 2251 |
|
|
2024
Q3 | $0 | Sell |
414
-225
| -35% | – | ﹤0.01% | 2243 |
|
|
2024
Q2 | $0 | Sell |
639
-4,770
| -88% | – | ﹤0.01% | 2204 |
|
|
2024
Q1 | $12K | Buy |
5,409
+2,707
| +100% | +$6.01K | ﹤0.01% | 1867 |
|
|
2023
Q4 | $5K | Sell |
2,702
-346
| -11% | -$640 | ﹤0.01% | 2119 |
|
|
2023
Q3 | $4K | Buy |
3,048
+132
| +5% | +$173 | ﹤0.01% | 2179 |
|
|
2023
Q2 | $6K | Buy |
2,916
+9
| +0.3% | +$19 | ﹤0.01% | 2203 |
|
|
2023
Q1 | $16K | Buy |
2,907
+2,051
| +240% | +$11.3K | ﹤0.01% | 2084 |
|
|
2022
Q4 | $7K | Buy |
+856
| New | +$7K | ﹤0.01% | 2226 |
|
|
2022
Q3 | – | Sell |
-5,669
| Closed | -$82K | – | 2281 |
|
|
2022
Q2 | $82K | Buy |
+5,669
| New | +$82K | ﹤0.01% | 1584 |
|